Recruiting Myasthenia Gravis Studies in San Francisco
About Myasthenia Gravis Clinical Trials in San Francisco
Myasthenia gravis is a chronic autoimmune neuromuscular disease that causes weakness in the skeletal muscles responsible for breathing and movement. It occurs when communication between nerves and muscles is disrupted. Treatment includes medications that improve neuromuscular transmission and immunosuppressive therapies.
There are currently 6 myasthenia gravis clinical trials recruiting participants in San Francisco, CA. These studies are seeking a combined 1,335 participants. Research is being sponsored by argenx, Immunovant Sciences GmbH, Sabine Mueller, MD, PhD and 3 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Myasthenia Gravis Clinical Trials in San Francisco — FAQ
Are there myasthenia gravis clinical trials in San Francisco?
Yes, there are 6 myasthenia gravis clinical trials currently recruiting in San Francisco, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in San Francisco?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the San Francisco research site will contact you about next steps.
Are clinical trials in San Francisco free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many San Francisco studies also compensate for your time and travel.
What myasthenia gravis treatments are being tested?
The 6 active trials in San Francisco are testing new therapies including novel drugs, biologics, and treatment approaches for myasthenia gravis.
Data updated October 12, 2026 from ClinicalTrials.gov